New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.
The supplement industry is booming—but so are serious health issues tied to taking these pills and powders. Here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results